v3.26.1
Common Stock (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Activities for the Restricted Stock Issued to Employees
The activities for the restricted stock issued to employees was as follows (in thousands, except per share data):
Number of
Shares		Weighted-
Average
Grant Date
Fair Value Per Share
Unvested restricted stock as of December 31, 202574 
Granted— $— 
Vested(74)$76.91 
Forfeited— $— 
Unvested restricted stock as of June 30, 2026— 
Schedule of Activity under the 2014 and 2020 Plans
A summary of stock option activity under the 2014 Equity Incentive Plan, 2020 Equity Incentive Plan, and 2022 Inducement Equity Incentive Plan was as follows (in millions, except share amounts which are reflected in thousands, and per share data):
Options Outstanding
Shares
subject to
Options
Outstanding		Weighted-
Average
Exercise
Price Per Share		Weighted-
Average
Remaining
Contractual
Term
(in years)		Aggregate
Intrinsic
Value
Balance as of December 31, 20252,411 $6.70 2.37$530 
Granted— $— 
Exercised(343)$4.30 $63 
Cancelled and forfeited(1)$13.50 
Balance as of June 30, 20262,067 $7.10 2.00$367 
Exercisable as of June 30, 20262,067 $7.10 2.00$367 
Vested and expected to vest as of June 30, 20262,067 $7.10 2.00$367 
Summary of RSU Activity
A summary of RSU activity was as follows (in millions, except share amounts which are reflected in thousands, and per share data):
Number of
Shares		Weighted-
Average
Grant Date
Fair Value Per Share		Aggregate
Intrinsic
Value
Unvested RSUs as of December 31, 202523,961 $5,427 
Granted9,611 $187.56 
Vested(4)$131.30 
Vested and settled(5,364)$125.43 
Forfeited(1,472)$169.16 
Unvested RSUs as of June 30, 202626,732 $4,933 
Schedule of Stock-based compensation Expense
The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in millions):
Three Months Ended June 30,Six Months Ended June 30,
2025202620252026
Cost of revenue, exclusive of depreciation and amortization$37 $48 $70 $83 
Sales and marketing33 35 59 58 
Research and development141 189 257 302 
General and administrative71 77 131 134 
Restructuring charges— — — 3 
Total stock-based compensation expense$282 $349 $517 $580